Pre Feasibility Report For Proposed Expansion of Synthetic...
Transcript of Pre Feasibility Report For Proposed Expansion of Synthetic...
Pre-Feasibility Report Megafine Pharma (P) Ltd
Pre Feasibility Report
For
Proposed Expansion of Synthetic Organic Chemicals (API’s & Drug Intermediates Manufacturing)
Schedule 5 (f)
Category A
Prepared By
M/s Megafine Pharma (P) Limited Plot No. 31 to 35, 48 to 51, 1 to 5, 26 & K (Gat No. 201),
Lakhamapur, Tal. Dindori, Dist. Nashik, Maharashtra,
Pin code : – 422202
Tel.: 02557 – 250121/22/23
Web: http://www.megafine.in/
Pre-Feasibility Report Megafine Pharma (P) Ltd
Table of contents
Contents 1 Executive Summary ......................................................................................................................... 2
I. Project at a glance ..................................................................................................................... 3
2 Introduction of the Project/Background information ........................................................ 5
II. Identification of the project and Project Proponent ............................................... 5
III. Brief description of nature of project ........................................................................... 5
IV. Need of the project and its importance to the country and region ................... 6
V. Demand and supply Gap .................................................................................................... 6
VI. Imports vs Indigenous production ................................................................................ 6
VII. Export Possibility / Domestic / Export Markets ...................................................... 7
Employment Generation due to Project (Direct and indirect) ......................................... 7
3 Type of Project ................................................................................................................................... 8
I. Type of Project ........................................................................................................................... 8
II. Location of the Project ........................................................................................................ 8
4 Site Analysis ...................................................................................................................................... 16
I. Connectivity ...................................................................................................................................... 16
II. Land form, Land use and Land ownership ............................................................................ 16
III. Topography (with Map) ............................................................................................................ 16
IV. Existing land use pattern .......................................................................................................... 16
V. Existing Infrastructure .................................................................................................................. 16
VI. Soil Classification ......................................................................................................................... 16
VII. Climate data from secondary sources ................................................................................. 17
VIII. Available social Infrastructure ............................................................................................... 17
5 Planning Brief ................................................................................................................................... 18
6 Proposed Infrastructure ............................................................................................................... 19
7 Rehabilitation and Resettlement (R & R Plan) .................................................................... 22
8 Project schedule and cost estimates ........................................................................................ 22
I. Time schedule of the Project ............................................................................................. 22
9 Analysis of Proposal ....................................................................................................................... 22
Pre-Feasibility Report Megafine Pharma (P) Ltd
Annexure details
Annex.
No.
Description
I GPS location, Map, project boundaries
II Product mix and production volume
III Indicative schematic diagram with brief process
description
IV Raw material quantities, storage details, mode of
transportation, physical state of materials
V Final product, physical state, mode of transportation
VI Effluent treatment block flow diagram
Pre-Feasibility Report Megafine Pharma (P) Ltd
2
1 Executive Summary
Megafine, established in 1995, is a privately owned and professionally managed
enterprise with it's corporate office in Mumbai and two multipurpose manufacturing
sites at Vapi & Nashik in India, both successfully inspected by US-FDA & the Nashik
facility is also approved by EMEA, PMDA & KFDA. Both the plants are also certified by
WHO GMP, ISO 9001:2008, 14001:2004 & OHSAS 18001:2007 and have been audited
by several Innovators and leading Generic companies from time to time.
Megafine provides innovative & integrated API solutions with it's decades of
experience and skill in the development of novel chemical processes catering to the
global drug discovery and generic companies. Our continuous investment in research
and development generates a steady flow of APIs enabling timely introduction of new
products in the market. Megafine is committed to respecting third party intellectual
property rights, manufacture products which are commercially competitive and meet
the most stringent quality standards. Besides manufacturing its own Active
Pharmaceutical Ingredients (APIs) & Advanced Intermediates, we also contract
manufacture for global drug discovery and generic companies.
Our focus is on niche products; with a presence in more than 40 countries. Our
partners are essentially drug discovery and generic drug companies across the globe
for whom we develop a range of new niche products in select therapeutic categories
like Anthelmintic, Cardiology, Urinary Incontinence, CNS (Central Nervous System), &
a few others. We supply a wide range of high quality generic and custom
manufactured APIs in volumes that range from a few grams to tons.
Megafine has special expertise in Polymorphs and Chiral products.
A perfect blend of Human talent, R&D Labs, Pilot Plant & cGMP manufacturing
facilities backed by our Quality Assurance, Regulatory Affairs and Intellectual
Property cell gives Megafine an edge.
Our regulatory team is well trained & experienced to comply with US-FDA, EDQM,
Japanese PMDA & other regulatory authority requirements. The company has over
150 regulatory filings across the globe for its APIs to its credit with an impressive
pipeline.
M/s. Megafine Pharma(P)Ltd is an existing Company having its unit located at Plot No.
31 to 35, 48 to 51, 1 to 5, 26 & K (Gut No.201), Village Lakhmapur,Taluka: Dindori,
Dist: Nashik -422 202 Maharashtra manufacturing synthetic organic compound as
Bulk Drugs / APIs and Advance Drug Intermediates for pharma Industry.
Now, the Company proposes to manufacture additional new products within its
existing premises as Advance Drug Intermediates and Bulk Drugs / APIs the site.
Pre-Feasibility Report Megafine Pharma (P) Ltd
3
Salient Project features are given below:
I. Project at a glance
Sr No Particulars Details 1 Name of Company M/s. Megafine Pharma (P) Ltd
Location Plot No. 31 to 35, 48 to 51, 1 to 5, 26 & K (Gut
No.201), Village Lakhmapur, Taluka: Dindori,
Dist. : Nashik -422 202, Maharashtra
2 Project Activity,
Category as per
amendments
Project schedule 5(f)- Synthetic Organic Chemicals,
Category A
Name of the project Expansion of Synthetic organic chemicals
(API’s & Drug Intermediates Manufacturing)
3 Total Land area 37,932 sq m
4 Existing built up area 20,227 sq m
5 Proposed additional
built up area
6,640 sq m
6 Proposed product with
capacity
Total 650 MTPA (Details Chapter no 2)
7 Raw material Details at chapter 3
8 Fresh water
requirement
Water Consumption: 350 KL/day, Sourced from
Maharashtra Irrigation department from Ozhar Khed
Dam and in case of shortage of water ground water
will be used.
(139.4 existing + 210.6 proposed)
Break up as follows:
Domestic : 50 CMD
Process : 60 CMD
Boiler and cooling : 230 CMD
Gardening : 10 CMD
Total : 350 CMD
Waste water with
mode of disposal
Domestic effluent : 40 CMD
Trade effluent : 92 CMD
Total : 132 CMD
Effluent shall be treated in existing system and
proposed ETP. Treated effluent shall be
recycled/reused to the extent and remaining shall be
disposed on land for gardening within premises.
There will be no discharge of effluent outside factory
premises; The unit shall be zero liquid discharge.
Pre-Feasibility Report Megafine Pharma (P) Ltd
4
Sr No Particulars Details 9 Power Existing requirement 1490 KVA proposed 750 KVA
(from MSEDCL)
Existing emergency DG sets of 2 x 750 KVA are
insufficient for expansion, hence 1 no. additional DG
(750 KVA) is proposed.
10 Manpower Existing 650 Nos + proposed addition of 100 Nos
11 Air emissions Proposed addition of 5 TPH steam boiler (biomass
briquettes fired) 875 kg/hr briquettes consumption.
OR
Proposed addition of 5 TPH steam boiler (HSD fired)
300 kg/hr HSD consumption.
Refer chapter 3 for details
12 Solid and hazardous
waste
Refer chapter 3
13 Project cost (estimate) 75 Crores
Pre-Feasibility Report Megafine Pharma (P) Ltd
5
2 Introduction of the Project/Background information
II. Identification of the project and Project Proponent
Megafine Pharma (P) Ltd. is a registered Private Limited company and is promoted
by following three Directors.
Sr.
No.
Name of
Directors Residential Address Qualification
1. Mr. Ashok K.
Jhaveri
190-B, Heera Panna Co-op. Hsg.
Soc., Bhulabhai Desai Road, Haji
Ali, Mumbai.
B. Tech. (Chem.)
I.I.T.-Delhi having
39 years of
experience
2. Mr. Hasmukh P.
Gandhi
701/ 702, Splendour Residency
Lawate Nagar, Near City Center
Mall
Nashik – 7
B. Sc. having 35
years of experience
3. Mr. Shailesh J.
Sanghvi
801-Jogani Apartment,
29-B Dongarsi Road,
Walkeshwar, Mumbai – 400
006.
B. Com. Having 25
years of experience
Unit is manufacturing various synthetic organic compounds as pharma
intermediates & bulk drugs for pharma industries.
M/s Megafine Pharma (P) Ltd. is having ISO certification for ISO 9001 and 14001
since 2003 and for OHSAS 18000 since 2007.
Unit is having Consent to operate BO/JD-PAMS/NK-12418/R/CC-1911 dated
04.03.2013 valid up to 31.02.2017 for manufacturing of existing products (Consent
amendment is under renewal)
The unit is a member of common hazardous waste treatment, storage and disposal
facility (CHWTSDF) for the disposal of hazardous solid/residual liquid waste
approved by Maharashtra Pollution Control Board (MPCB) i.e. M/s Maharashtra
Enviro Power Ltd. plot no P-56, Ranjangaon MIDC Taluka Shirur, Pune-412 220.
III. Brief description of nature of project
M/s. Megafine Pharma (P)Ltd is an existing Company having its unit located at Plot
No. 31 to 35, 48 to 51, 1 to 5, 26 & K (Gut No.201), Village Lakhmapur,Taluka: Dindori,
Dist. : Nashik -422 202, Maharashtra manufacturing synthetic organic chemicals as
bulk drugs and pharma intermediates for Pharma Industry having 338.3 MTPA
capacity.
Pre-Feasibility Report Megafine Pharma (P) Ltd
6
Now, the Company propose to manufacture additional new products within its
existing unit & proposed new block for bulk drugs/APIs & Pharma Intermediates with
additional manufacture of 311.7 MTPA which are synthetic organic chemicals, at Plot
No. 31 to 35, 48 to 51, 1 to 5, 26 & K (Gut No.201), Village Lakhmapur,Taluka: Dindori,
Dist. : Nashik -422 202, Maharashtra.
For the proposed expansion project, the company proposes to use in-house developed
ready technology and intends to procure the available latest technology for
manufacturing the proposed products.
The pharma / health industrial sector in the past many years has seen a consistent
growth and also keeping in mind our strong presence in the local & global market.
Hence we have identified the demand for the proposed products which are meant for
very new medicines meant for fast growing therapeutic segments like Cardiac, Neuro,
Pulmonary, Diabetic, etc. with R&D developed our own process patents we can take a
lead & produce commercially in bulk for domestic market as well as with strong
presence in export markets.
As per the EIA notification‐ 2006 (as amended) the proposed new project involves the production of “Pharma Intermediates and APIs” which falls under schedule no. “5(f) – Synthetics Organic Chemical Industries “as per the EIA notification- 2006, requires prior Environmental Clearance.
IV. Need of the project and its importance to the country and region
The proposed expansion project will provide a potential & required growth opportunity for the already running business of the company. The company is US FDA approved facility since 2008. Moreover company has strong presence with leading pharma cos. locally as-well-as internationally; mainly in regulated market. The company & the products are well approved & registered with the leading regulatory authorities & the pharma customers’ in local & international markets.
V. Demand and supply Gap
The products have very good demand & high potential as Pharma Intermediates and bulk drugs/APIs for Pharmaceutical Industries.
VI. Imports vs Indigenous production
Proposed products manufacturing in the country will be very much viable & acceptable compare to imports due to our grass-root technology, efficient productivity and EHS-GMP compliances. Our products approval & DMF filing for leading overseas customers gives tremendous boost to our export; which earns valued forex revenue generation for our county.
Pre-Feasibility Report Megafine Pharma (P) Ltd
7
VII. Export Possibility / Domestic / Export Markets
There is a fast growing demand of the proposed products in the export & our local market. Our products are widely used and are in huge demand in the domestic pharma/health industry.
Employment Generation due to Project (Direct and indirect)
There will be very good opportunity of employment generation of additional qualified staff & unqualified workers directly for 100 nos. and indirectly for 50 nos.) Due to proposed expansion project.
Pre-Feasibility Report Megafine Pharma (P) Ltd
8
3 Type of Project
I. Type of Project (including interlinked and interdependent projects if any)
The proposed project is not interlinked and inter dependent project of the company.
II. Location of the Project (map showing general location, specific location, and project boundary and project
site layout) with coordinates)
The map showing general location, specific location and project boundary and project
site layout of M/s. Megafine Pharma(P)Ltd unit located at Plot No. 31 to 35, 48 to 51,
1 to 5, 26 & K (Gut No.201), Village Lakhmapur,Taluka: Dindori, Dist. : Nashik -422
202, Maharashtra is given at Annexure I.
The longitude and latitude of the project site is 20°15’35.68”N and 73°50’36.76”E.
Site coordinates are as follows:
Direction Longitude Latitude
North east corner 20°15’38.09”N 73°50’42.98”E
North west corner 20°15’41.15”N 73°50’36.11”E
South east corner 20°15’29.26”N 73°50’34.89”E
South west corner 20°15’31.42”N 73°50’40.62”E
Refer Annexure I for GPS location and map.
Profile of Project Site:
Plot Area Statement:
Sr. No.
Items Area After Proposed
Expansion (in m2) 1 Total Plot Area 37,932 2 Existing Built up area 20,227 3 Proposed Built up area 6,640 4 Green belt Area (approx.) 5000
Details of Infrastructure:
Sr. No.
Nearest Infrastructure Feature Distance from Project Site
1 Geographical Position 20°15’35.68”N and 73°50’36.76”E 2 Elevation above Sea Level 571 Meters (Approx.) 3 Nearest Village Lakhmapur (1.0 KM to W) 4 Nearest Town Dindori (4.5 km SE) 5 Nearest National Highway NH -3 (22 KM E) 6 Nearest State Highway SH -17 (1.0 KM approx.) E 8 Nearer RW Station Nashik Road 55 KM (Approx.) 9 Nearest Airport Nashik airport 45 KM & Mumbai- 200
Pre-Feasibility Report Megafine Pharma (P) Ltd
9
KM approx.
10 Nearest Surface water Resource / Reservoir
Ozhar Khed Dam Approx. 5 KM. on North side.
11 Forest Patches No patches of Reserve Forest within the study area of project site.
12 Location of Archaeologically / Historically important places
--
13 National Park/Sanctuary or Ecologically sensitive Area
--
14 National or State Boundary Saputara , Gujarat Approx 65 KM. 15 Tourist Places Nashik Panchvati Approx. 40 KM.
16 Selection of project Site and Detail of alternate Site.
Proposed project is in the private Industrial area. Alternate site consideration is not envisaged.
17 Size or Magnitude of Operation Large scale Industry
Figure 3-1 Site layout
Pre-Feasibility Report Megafine Pharma (P) Ltd
10
III. Details of the alternative sites considered (basis of electing the proposed
site, particularly environmental considerations gone into should be highlighted)
No alternate site is considered. Existing site has excellent plant and infrastructure for the
proposed expansion.
IV. Size and magnitude of Operation
Existing products list and proposed products therapeutic category wise is given
below.
Sr.No
.
Therapeutic Category (type)
Existing capacity (MTPA)
Proposed capacity (MTPA)
Total (MTPA)
1 Coagulant 0.45 9.15 9.60 2 Antidepressants 46.30 61.80 108.10 3 Thrombotic 0.25 2.25 2.50 4 Alzhemiers 4.00 3.50 7.50 5 Antianginal 0.10 0.45 0.55 6 Anithypertensive 57.20 3.25 60.45 7 Scziophrenia 54.50 48.30 102.80 8 Over Active Bladder 1.55 2.40 3.95 9 Multiple sclerosis 12.00 -7.00 5.00
10 Acute coronary syndrome
0.35 0.20 0.55
11 Psoriatic Arthritis 0.00 1.50 1.50 12 Cystic fibrosis 0.00 1.10 1.10 13 Insomnia 0.00 0.80 0.80 14 Antiemetic 0.00 0.60 0.60 15 Antidiabetic 0.50 3.50 4.00 16 Anti occular
Hypertensive. 0.10 0.40 0.50
17 Cough suppressant and not antidepressants
0.00 15.00 15.00
18 Antifungal 25.00 0.00 25.00 19 Anthelmentic 136.00 164.00 300.00 20 Post Operative
Distention 0.00 0.50 0.50
Total 338.3 311.7 650.0 Note – proposed quantity For Sr No 9, Existing quantity is 12 MTPA, which we wish to
reduce by 7 MTPA due to less market demand.
Product mix and production volume is at Annexure II
V. Project description with process details (schematic diagram / flow chart showing the project layout components of the project
etc)
The project pertains to manufacture of various categories API’s/Bulk drugs. Indicative
schematic diagram with brief process description is given at Annexure III
Pre-Feasibility Report Megafine Pharma (P) Ltd
11
VI. Raw material required (along with estimated quantity, likely source, marketing area of final products, mode of
transport of raw material and final product)
Raw material
Sr.No. Particulars Unit
Estimated Qty. per year
Likely source Mode of transportation
Existing proposed
Refer Annxure IV
Raw material (Major) (……. For others refer Annexure IV)
Sr.No. Particulars Unit
Estimated Qty. per month Likely source
Mode of transportation
Existing proposed
1 Aq Ammonia MT 8 13 Local Tanker
2 MDC MT 125 140 Local Tanker
3 IPA MT 20 35 Local Tanker
4 Methanol MT 55 135 Local Tanker
5 Ethanol MT 23 25 Local Tanker
6 Ethyl acetate MT 48 98 Local Tanker
7 Acetone MT 28 24 Local Tanker
8 Toluene MT 50 150 Local Tanker
Raw material (Major – storage details)
Sr.No. Particulars Unit Physical state
Storage capacity (KL) Stored in
Existing proposed
1 Aq Ammonia KL Liquid 12 - Tank
2 MDC KL Liquid 24 - Tank
3 IPA KL Liquid 24 - Tank
4 Methanol KL Liquid 28 - Tank
5 Ethanol KL Liquid 28 - Tank
6 Ethyl acetate KL Liquid 28 - Tank
7 Acetone KL Liquid 28 - Tank
8 Toluene KL Liquid 28 - Tank
Final Products
Sr.No Particulars Unit Physical state (Liquid/Solid/Gas) Mode of transportation
Refer Annxeure V
Manpower:
Description Existing, No Proposed, No Total, No Permanent 450 60 510
Contract 200 40 240 Total 650 100 750
Pre-Feasibility Report Megafine Pharma (P) Ltd
12
VII. Resource Optimization (recycle and reuse envisaged in the project)
The materials are packed in drums and stored in a very organized way, segregated as
Solid and Liquid area in warehouse. We have good practices in place like good house
keeping, good Manufacturing practices, best Environment control, safety and health
practices. By adoption of continuous improvement in technology and processes the
desired reduction in process waste generation will be achieved. By proper and
efficient handling of raw materials, wastages of raw materials will be reduced. By
most efficient solvent recovery facilities established with additional high capacity hi-
tech distillation plant together with latest evolved box type condensers; we will
reduce the solvent losses to bear minimum.
Treated effluent shall be recycled/reused in the plant processes.
VIII. Availability of Resources (Water, Energy/Power Requirement - source)
Estimated fresh water intake breaks up
No. Description Existing water input
(cmd)
Proposed water input
(cmd)
Total water input (existing
+ proposed)(cmd)
1. Domestic 15 35 50 2. Processing whereby water
gets polluted and pollutants are easily biodegradable
15.9 44.1 60
3. Industrial cooling/boilers 103 127 230 4. Gardening 5.5 4.5 10 Total 139.4 210.6 350
Source of supply : Fresh water requirement will be catered from Govt. Irrigation dept. (Palkhed Division Nashik)(from Ozar khed dam).
Power requirement: Power requirement for the expansion shall be 750 KVA from
MSEDCL
IX. Quantity of waste to be generated (liquid and solid, scheme for their
management/disposal)
Waste Water
Estimated waste water
No. Description Existing generation
(cmd)
Proposed generation
(cmd)
Total (cmd) Disposal
A B A+B 1. Trade effluent 18.4 73.6 92 Recycle / reuse at
site. No discharge outside. ZLD unit
2. Domestic 12 28 40 Treated at STP and
Pre-Feasibility Report Megafine Pharma (P) Ltd
13
effluent treated water used for gardening
Total 30.4 101.6 132 - Effluent treatment block diagram is at Annexure VI.
Waste Generation and its treatment, disposal
I. Solid Waste
(a) Non Hazardous Solid Waste:
Consented quantities of Solid waste generation and proposed solid wastes are:
Sr No
Type of Waste Existing Quantity
Proposed Quantity
Disposal method
1 Boiler Ash 0.8 MT /D 2.8 MT/D Landfill / brick manufacturer
2. Empty Containers (MS/Fibre Drums/Glass
Bottles etc.) 720 Nos /A 3000 Nos /A
After decontaimination Sold to scrap dealers.
3. Empty Containers
HDPE Drums 0.00 4000 nos/A
After decontaimination Sold to scrap dealers.
4. HDPE bags. 3000 Nos.
/A 6000 Nos/A
After decontaimination Sold to scrap dealers.
5. Paper waste 0.00 3.6 MT/A Sold to scrap dealers. 6. Scrap (MS/SS) 0.00 6 M/A Sold to scrap dealers.
(b) Hazardous Waste:
The quantification of hazardous solid waste generated from present activity and
proposed activities is presented as follows:
Sr No
Waste type Category no /
schedule
Existing Quantity
Proposed Quantity
Disposal
1 Waste/residue containing oil
5.2 0.6 MT/A 1.0 MT/A Sale to authorised
reprocessor 2 Distillation residue 20.3 2.58
MT/A 5.0 MT/A CHWTSDF
3 Spent catalyst/spent carbon
28.2 4.90 MT/A
10.0 MT/A CHWTSDF
4 Spent catalyst/spent carbon
28.2 0.15 MT/A
0.30 MT/A CHWTSDF
5 Discarded containers barrels/ liners
33.3 5400 No/A
7500 No /A Sale to authrorised
reconditioner 6 Discarded containers
barrels / liners 33.3 144 No/A 300 No/A CHWTSDF
7 Spent organic solvent 28.5 2220.8 MT/A
2220.8 MT/A
Sale to authorised
recycler 8 Chemical sludge from
waste water treatment 34.3 237.94
MT/A 237.94 MT/A
CHWTSDF
Pre-Feasibility Report Megafine Pharma (P) Ltd
14
Sr No
Waste type Category no /
schedule
Existing Quantity
Proposed Quantity
Disposal
9 Filters and filter matter which have organic
liquid.
35.1 2490 No/A
2490 No/A CHWTSDF
10 Waste/residue containing oil
5.2 0.1 MT/A 0.5 MT/A CHWTSDF
Steam / Process heat Requirement: The steam requirement and process heat
requirement for the proposed expansion shall be met from the existing and new steam
generator and existing Thermic fluid heater. The fuel requirement shall be as follows :
Sr
No Fuel
Daily consumption Air
Pollution
Control
Measures
Pollutants Remark Existing Proposed
1
Briquettes
OR
HSD
8 MTPD
-
-
21 MTPD
OR
7200 kg
per day
Adequate
stack height
and dust
collection
system is in
place. Similar
arrangement
shall be
provided for
proposed
boiler.
SPM,SOX,
NOX
Existing
for 2 TPH
and
proposed
for 5 TPH
steam
2 Diesel 32.8
lit/hr Nil
Adequate
stack height
SPM,SOX,
NOX
For
existing
600 kg
steam
boiler
3 Diesel 37.2
lit/hr Nil
Adequate
stack height
SPM,SOX,
NOX
For 2
lackcal/hr
TFH
Source of fuel : Briquettes from nearby Sugar factory.
Mode of transport to site: by truck
DG Set:
Existing DG 2 sets of total 2 x 750 KVA are not adequate for the expansion and hence
there is proposal to add one new DG set. Their fuel requirement (only in case of
emergency) shall be as follows:
Sr
No Fuel
Daily consumption
Existing (2 x 750 Proposed 1 x 750 KVA
Pre-Feasibility Report Megafine Pharma (P) Ltd
15
KVA)
1
Diesel for DG
sets(emergency
requirement
only)
150 Lit/hr (at full
load) for one DG set 150 Lit/hr (at full load)
X. Schematic representation of feasibility drawing which gives EIA
purpose
The applicability of the EIA Notification 2006, for the proposed project was explored by considering different possibilities & provision made in the said notification considering the products & project location.
Pre-Feasibility Report Megafine Pharma (P) Ltd
16
4 Site Analysis
I. Connectivity
The project is located at Plot No. 31 to 35, 48 to 51, 1 to 5, 26 & K Gut no 201, Lakhmapur village, Tal Dindori Dist Nashik.
It is 1 km away from state highway no 17.
Nearest railway station is Nashik road at 40 km (approx.)
Nearest airport is Nashik at 45 km
Mumbai JNPT port is 200 km away from site
II. Land form, Land use and Land ownership
Land ownership is with the project proponent (Megafine) and is for industrial use.
III. Topography (with Map)
Refer Topomap
IV. Existing land use pattern
The existing use is for industrial purpose.
V. Existing Infrastructure
Site is well developed for industrial use with infrastructure such as road, electricity,
water supply, education and medical facilities.
VI. Soil Classification
The district forms part of Western Ghat and Deccan Plateau. Physiographically Nasik district comprises varied topography. The main system of hills is Sahayadri and its offshoots viz., Satmala, Selbari and Dolbari hill ranges. These hill ranges along with eastern and southern plains and Godavari valley are the distinct physiographic units. The northern part of the district falls under Tapi basin and is drained by easterly flowing Girna River along with its tributaries, whereas the southern part of the district falls under Godavari basin an is drained by Godavari River and its tributaries. Other important rivers in the district are Damanganga, Vaitarna, Darna, Kadva, Aram, Mosam, Panjan and Manegad. The soils of the district are the weathering products of Basalt and have various shades from gray to black, red and pink color. The soils occurring in the district are classified in the four categories namely lateritic black soil (Kali), reddish brown soil (Mal), coarse shallow reddish black soil (Koral), medium light brownish black soil (Barad). In
Pre-Feasibility Report Megafine Pharma (P) Ltd
17
general the soils are very fertile and suitable for growing cereal and pulses. The black soil contains high alumina and carbonates of calcium and magnesium with variable amounts of potash, low nitrogen and phosphorus. The red soil is less common and is suitable for cultivation under a heavy and consistent rainfall.
VII. Climate data from secondary sources
The climate of the district is on the whole is agreeable. The climate of Nashik district is characterized, by general dryness throughout the year except during the south-west monsoon season. The winter season is from December to about the middle of February followed by summer season which last up to May.
June to September is the south-west monsoon season, whereas October and November constitute the post-monsoon season. The maximum temperature in summer is 42.5°C and minimum temperature in winter is less than 5.0°C. Relative humidity ranges from 43% to 62%. The normal annual rainfall in the district varies from about 500 mm to 3400 mm. It is minimum in the north eastern part of the district and increases towards west and reaches a maximum around Igatpuri in the western ghat. The chances of receiving normal rainfall are maximum (50 to 55%) in the north eastern part around Malegaon and Nandgaon and minimum in the central part of the district. The study of negative departures of the annual rainfall over normal reveals that major part of the district (about 75%) falling east of Western Ghats comprising almost entire Sinnar, Niphad, Surgana, Kalvan, Satana, Chandwad, Yeola talukas and parts of Dindori, Peint and Malegaon talukas can be categorized as drought area.
VIII. Available social Infrastructure
Hospitals, educational facilities, primary health center is available within 5 km
distance. Major town near is Dindori which is Taluka place. Nasik (district
headquarter) is at about 30 km away where higher educational & recreational
facilities are available,
Pre-Feasibility Report Megafine Pharma (P) Ltd
18
5 Planning Brief
I. Planning concept
Expansion is at existing plot of the company
Purified Water supply from Irrigation department
State highway 1 km away from site
Integration with the existing manufacturing facility
II. Population projection Not applicable
III. Land use planning (break up with green belt)
The project is located within the existing plot area by the company and due to the
proposed project there will not be any change in the land use pattern of the region.
Plot Area Statement is as follows:
Area Statement Area After Proposed Expansion
(m2)
Total Area 37,932
Existing built up
Area 20,227
Proposed built
area 6,640
Greenbelt Area 5,000
IV. Assessment of Infrastructure demand (physical and social) The proposed infrastructure to manufacture products will be built with standard
engineering design considering all the relevant parameters related to environment, health
and safety. Facilities like road and communication are good. Banks, ATM's and medical
facilities are also adequate.
V. Amenities and Facilities
The site is well connected by road. The state highway is just 1 km away from site.
Hospital, educational facility, primary health centre is available within 5 km distance.
Major town near is Dindori which is Taluka place. Nasik (district headquarter) is at
about 30 km away where higher educational & recreational facilities are available.
Pre-Feasibility Report Megafine Pharma (P) Ltd
19
6 Proposed Infrastructure
I. Industrial area
Basic infrastructure developed already and the required additional plant and machineries
will be installed after getting statutory clearance.
II. Residential Area No residential area is involved in the proposed project. The employs are accommodated in
nearby Residential areas
III. Green Belt
Sufficient green belt area will be provided and maintained at the project site. It will be
to the tune of 12 % of the open land area within plant site premises.
IV. Social Infrastructure Employment will be provided to locals as per the skills and requirement.
V. Connectivity Mentioned at 4.1 Site analysis
VI. Drinking water Management (source and supply of water) Drinking water requirement shall be met through the supply from Irrigation
department. Estimated quantity of drinking water shall be 30 KL/day.
VII. Sewage System There is existing sewage treatment plant of adequate capacity (48 KL/day). The
details of which is given below.
To treat above Sewage the Sewage Treatment Plant has following components.
Screen Chamber: To remove the coarse particles such as plastic, wood pieces, etc.
in sewage water.
Equalization Tank: To Equalize the incoming sewage water & to ionize the water.
Electro Ionizer: To reduce the smell & to ionize the water molecule & separate
dissolved ions.
Electro Cell: Electrolysis process occurs here, which results in coagulation of
sewage, destabilizing the colloidal & suspended impurities.
Sand Filter: To filter the coagulated water
Activated Carbon Filter: It removes organic constituents & residual disinfectants.
Electrolyser: It produces the chlorine for disinfection purpose. Chlorine
containing water is added in treated water tank.
Softener: To reduce the hardness up to 100 ppm.
The sewage water is treated by electrolytic process post to collection tank which is
chemical free, on biological & environment friendly.
Pre-Feasibility Report Megafine Pharma (P) Ltd
20
The process is based on Electrolysis. Electro coagulation is technique involving
passage of electricity through the sewage. He electric current destabilizes dissolved
colloidal particles and alters the charge on suspended particles permitting purification
of water.
Initially the sewage is collected in Equalization tank from various locations through
bar screen chamber Tank having baffle wall to improve settling rate. Then this sewage
is pump out 50 % to electro-ionizer & 50 % to Electro-cell. The ionizer reduces the
smell & ionizes the received sewage and again this sewage transfers to equalization
tank. This cycle of ionization is continuously performed by ionizer. Then this ionized
sewage goes to Electro-cell where Electro coagulation process takes place,& the
sludge separated during this process goes to sludge holding tank. The clear water
proceed to filter no. 01 which is sand filter , then to filter no.02 which is a charcoal
filter which functions to remove organic constituents & residual disinfectants. While
electrolytic coagulation in Electro-cell the addition of Sodium Hypochlorite solution is
also continue in sewage from the top of Electro-cell drop wise. The sodium
hypochlorite functions as a disinfectant & to remove smell of sewage. Then the treated
sewage is collected in collection tank, this treated sewage is used for toilet flushing,
gardening purpose.
The sludge collected in sludge holding tank is pumped out to sludge drying beds to dry
the sludge as per requirement, then this dry sludge is collected and dispose to Land
fill.
Everyday backwash is given to sand & charcoal filter & electro-cell electrodes &
ionizer electrodes are cleaned with raw water to remove scaling deposited on
electrodes.
Thus the treated sewage has Total Suspended Solids less than 100 mg/L & BOD 3 days
27O C less than 100 mg/L. Treated sewage water is used for gardening in company
premises.
Process flow diagram is as follows.
Pre-Feasibility Report Megafine Pharma (P) Ltd
21
VIII. Industrial waste management Refer chapter 3 above
IX. Solid waste management Refer chapter 3 above
X. Power Requirement & Supply/ Source Power requirement of the expansion is 750 KVA and shall be sourced from
MSEDCL.
Pre-Feasibility Report Megafine Pharma (P) Ltd
22
7 Rehabilitation and Resettlement (R & R Plan)
The proposed activities are in the existing plot of the company which is located at Plot No. 31 to 35, 48 to 51, 1 to 5, 26 & K (Gat No. 201), Lakhmaur, Tal Dindori Dist Nashik. It does not require acquisition of Land and the Infrastructure so there is no any kind of
activity of Rehabilitation and Resettlement carried out.
8 Project schedule and cost estimates
I. Time schedule of the Project
After obtaining Environmental clearance from MOeFCC and Consent to Establish from
MPCB, the company shall start the proposed construction activity of the project.
The project shall be executed in phased manner in the overall period of 5 years.
II. Estimated project cost (Economic Viability of the Project)
Estimated cost for the proposed expansion shall be 75 Crores (This is for Plant &
Machinery, Pipeline & Fittings, Electrical / Instrumentation Installation, Safety systems,
Environmental protection systems, green belt development etc.. are the major heads
considered in the Capital Cost Projection for the proposed expansion project.)
9 Analysis of Proposal
I. Financial and Social Benefits
Proposed expansion activity will provide benefits to the local people in terms of financial
and social welfare.
Local people will get direct financial benefit by way of employment.
Local people will get some contracts of supply and services to get indirect income.
Company will contribute in improving education and health facilities in nearby
area.